The funding round was led by private equity firm Traditum and will support team expansion and sales growth.
"After Satish’s tragic death at the prime of his life and from a condition that could have been prevented, we resolved to find a way to save lives by helping people improve their overall health before any symptoms arise,"
— Michael Stein, Physiologist and serial entrepreneur
The £108m investment was led by backers including NatWest, LC Nueva, and Auluk Investments to fund product development and growth.
"We are thrilled to close this latest round of funding, where our debt and equity partners have demonstrated their belief in Updraft’s team and our mission, particularly in the current macroeconomic environment. It is a testament to what Updraft is trying to do; provide real solutions to customers to help them find their financial freedom. We have big ambitions planned for 2023, and this recent fundraiser puts us in a great position to help even more people."
IW Capital has provided an additional £800k to support the retail technology developer as it scales its operations.
"Ubamarket is disrupting the traditional shopping experience with their Scan Pay Go technology seen across the retail industry today. It has developed a compelling Scan Pay Go app with its patented technology and is now ready to roll out at scale. IW Capital is excited to be backing Ubamarket at a fundamental time as they scale up their technology offering and expand globally. Their technology improves businesses and customer experiences alike."
Phoenix Group joins existing backers Legal & General and Lloyds Banking Group as a co-lead investor in the business.
"This additional investment from Phoenix Group, following our long-standing commercial relationship with its Standard Life business, is further testament to the growing possibilities the industry sees in Open Data, and the transformational role Moneyhub can play. We are delighted that Phoenix Group has chosen to go even further by investing in the business. With Consumer Duty and Pensions Dashboard driving the need to focus on consumer outcomes, the only answer is to work in a trusted data sharing approach with your customers."
The grant funding will support the development and launch of a molecular tuberculosis testing system for developing countries.
"The advancement of our TB molecular test signifies an important step forward in LumiraDx’s mission to increase access to accurate and affordable testing worldwide as well as an important step forward in our molecular testing technology. The support from the Gates Foundation is critical in our development of the TB test and ensuring it reaches communities where access to testing is most challenged. The availability of these immediate results can be game changing."